Rogocekib
Rogocekib is an orally effective CLK 2 inhibitor, with an IC50 of 1.4 nM, showing anti-tumor activity[1][2].
Product Specifications
CAS Number
2144751-78-8
Product Name Alternative
CTX-712
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ctx-712.html
Purity
98.60
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
CC1=NC2=NC=C(C3=C4C(OC)=NC=NN4C=C3)C=C2N1CC5=NN=C([C@H](F)C)O5
Molecular Formula
C19H17FN8O2
Molecular Weight
408.39
References & Citations
[1]Akinori Yoda, et al. CTX-712, a Novel Clk Inhibitor Targeting Myeloid Neoplasms with SRSF2 Mutation. Blood. (2021) 205–206 |[2]Zhen Qin, et al. Development of Cdc2-like Kinase 2 Inhibitors: Achievements and Future Directions. J Med Chem. 2021 Sep 23;64 (18) :13191-13211.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
CLK
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
27215126 3x 1.0µg DNA
LOC498084 CRISPRa sgRNA lentivector (set of three targets)(Rat)
Sign In for Pricing
View Details 
GTR15301672 1 Vial
Lentiviral mouse Ankrd63 shRNA (UAS) - Lentiviral mouse Ankrd63 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details